DAVITA INC. Current Federal Tax Expense (Benefit)
DAVITA INC. (DVA) reported Current Federal Tax Expense (Benefit) of $134.29 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2026-02-11
- DAVITA INC. current federal tax expense (benefit) for fiscal 2025 was $134.29M, a 47.03% decline from fiscal 2024.
- DAVITA INC. current federal tax expense (benefit) for fiscal 2024 was $253.50M, a 26.71% increase from fiscal 2023.
- DAVITA INC. current federal tax expense (benefit) for fiscal 2023 was $200.07M, a 0.92% decline from fiscal 2022.
- DAVITA INC. current federal tax expense (benefit) for fiscal 2022 was $201.93M, a 6.75% decline from fiscal 2021.
| Period end | Current Federal Tax Expense (Benefit) 12 month | Current Federal Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $134.29M 10-K · filed 2026-02-11 | |
| 2024-12-31 | $253.50M 10-K · filed 2026-02-11 | |
| 2023-12-31 | $200.07M 10-K · filed 2026-02-11 | |
| 2022-12-31 | $201.93M 10-K · filed 2025-02-13 | |
| 2021-12-31 | $216.54M 10-K · filed 2024-02-14 | |
| 2020-12-31 | $47.17M 10-K · filed 2023-02-22 | |
| 2019-12-31 | $208.34M 10-K · filed 2022-02-11 | |
| 2018-12-31 | $140.06M 10-K · filed 2021-02-12 | |
| 2017-12-31 | $330.19M 10-K · filed 2020-02-21 | |
| 2016-12-31 | $322.94M 10-K · filed 2019-02-22 | $337.18M 10-K · filed 2017-02-24 |
| 2015-12-31 | $124.50M 10-K · filed 2018-02-23 | $183.26M 10-K · filed 2016-02-26 |
| 2014-12-31 | $188.30M 10-K · filed 2017-02-24 | |
| 2013-12-31 | $334.26M 10-K · filed 2016-02-26 | |
| 2012-12-31 | $239.23M 10-K · filed 2015-02-26 | $263.13M 10-K · filed 2013-03-01 |
| 2011-12-31 | $202.73M 10-K · filed 2014-02-21 | $217.88M 10-K · filed 2012-02-24 |
| 2010-12-31 | $153.50M 10-K · filed 2013-03-01 | |
| 2009-12-31 | $193.18M 8-K · filed 2012-07-06 | |
| 2008-12-31 | $118.76M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |